Fol. Biol. 2012, 58, 57-63
https://doi.org/10.14712/fb2012058020057
Novel Flow Cytometric Method for the Detection of Podocalyxin-Positive Elements in Urine of Patients with Glomerulonephritides – First Promising Results
References
1. 2008) Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrol. Dial. Transplant. 23, 3138-3145.
< , J., Mengel, M., Tossidou, I., Peters, I., Park, J. K., Haubitz, M., Schiffer, M. (https://doi.org/10.1093/ndt/gfn235>
2. 2009) Recruitment of podocytes from glomerular parietal epithelial cells. J. Am. Soc. Nephrol. 20, 333-343.
< , D., Kershaw, D. B., Smeets, B., Yuan, G., Fuss, A., Frye, B., Moeller, M. J. (https://doi.org/10.1681/ASN.2008070795>
3. 2005) Podocytopathie and transdifferentiation of the podocytes in human glomerulonephritis. An immunomorphological study. Bull. Acad. Natl. Med. 189, 535-545.
, J., Bruneval, P., Meyrier, A., Jacquot, C. (
4. 2006) Parietal podocytes in normal human glomeruli. J. Am. Soc. Nephrol. 17, 2770-2780.
< , J., Mandet, C., Hill, G. S., Bruneval, P. (https://doi.org/10.1681/ASN.2006040325>
5. 2008) A novel method for the estimation of podocyte injury: podocalyxin-positive elements in urine. Folia Biol. (Praha) 54, 162-167.
, P., Marečková, H., Sopková, Z., Malíčkova, K., Živorová, D., Zima, T., Tesař, V. (
6. 1995) Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron 69, 397-403.
< , M., Yamamoto, T., Yanagihara, T., Takada, T., Itoh, M., Adachi, Y., Kihara, I. (https://doi.org/10.1159/000188509>
7. 1998) Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am. J. Nephrol. 18, 35-41.
< , M., Yanagihara, T., Takada, T., Itoh, M., Matsuno, M., Yamamoto, T., Kihara, I. (https://doi.org/10.1159/000013302>
8. 2003) Urinary sediment podocalyxin in children with glomerular diseases. Nephron Clin. Pract. 95, 91-99.
< , K., Kawachi, H., Uchida, Y., Hara, M., Shimizu, F., Uchiyama, M. (https://doi.org/10.1159/000074322>
9. 2002) Podocyte biology and response to injury. J. Am. Soc. Nephrol. 13, 3005-3015.
< , P., Shankland, S. J. (https://doi.org/10.1097/01.ASN.0000039661.06947.FD>
10. 2003) Cell biology of the glomerular podocyte. Physiol. Rev. 83, 253-307.
< , H., Kriz, W., Kretzler, M. (https://doi.org/10.1152/physrev.00020.2002>
11. 2003) Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int. 64, 1222-1231.
< , A. T., Krofft, R., Blonski, M., Hiromura, K., Vaughn, M., Pichler, R., Griffin, S., Wada, T., Pippin, J., Durvasula, R., Shankland, S. J. (https://doi.org/10.1046/j.1523-1755.2003.00217.x>
12. 2007) Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin. Pract. 106, 61-66.
< , A., Floege, J. (https://doi.org/10.1159/000101799>
13. 2010) Conditionally immortalized human podocyte cell lines established from urine. Am. J. Physiol. Renal Physiol. 298, 557-567.
< , T., Abe, Y., Kajiyama, H., Bartlett, L. D., Howard, L. V., Jat, P. S., Kopp, J. B. (https://doi.org/10.1152/ajprenal.00509.2009>
14. 2004) The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J. Am. Soc. Nephrol. 15, 928-939.
< , B., Te Loeke, N. A., Dijkman, H. B., Steenbergen, M. L., Lensen, J. F., Begieneman, M. P., van Kuppevelt, T. H., Wetzels, J. F. M., Steenbergen, E. J. (https://doi.org/10.1097/01.ASN.0000120559.09189.82>
15. 2011) Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 22, 1262-1274.
< , B., Kuppe, C., Sicking, E. M., Fuss, A., Jirak, P., van Kuppevelt, T. H., Moeller, M. J. (https://doi.org/10.1681/ASN.2010090970>
16. 2003) Urinary excretion of viable podocytes in health and renal disease. Am. J. Physiol. Renal Physiol. 285, 40-48.
< , S. U., Nelson, W. J., Myers, B. D., Lemley, K. V. (https://doi.org/10.1152/ajprenal.00404.2002>
17. 2005) Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J. Am. Soc. Nephrol. 16, 1733-1741.
< , D., Petermann, A., Kunter, U., Rong, S., Shankland, S. J., Floege, J. (https://doi.org/10.1681/ASN.2005020159>